The purpose of this study is to find out if treatment with the study drug, Bexmarilimab, along with standard of care can help with your type of cancer.
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Joshua Zeidner
Medicine-Hematology
Clinical or Medical
Interventional
Cancer (Leukemia)
23-0853
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
